Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Breyner is a French company specializing in the development and distribution of bioactive treatments for the textile industry, with a strong focus on health and environmental safety. The company is best known for its flagship brand, Greenfirst, which utilizes plant-based active ingredients like geraniol to provide protection against dust mites, mosquitoes, and bedbugs. These treatments are widely integrated into bedding, upholstery, and clothing to help prevent allergies and vector-borne diseases. Breyner emphasizes sustainability, offering biodegradable and Oeko-Tex certified solutions that avoid traditional synthetic pesticides. Beyond product supply, the company provides technical expertise and quality control services to ensure the effective application of its formulations. Headquartered near Lyon, Breyner serves an international market of textile manufacturers seeking high-performance, eco-friendly hygiene finishes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BREYNER.